SCHEMBL6985404

SCHEMBL6985404

CCOCCCn1c(CCc2ccc(C#N)cc2)nc2cc(N(CCN(CC)CC)S(=O)(=O)c3ccccc3)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.40
HDAC8 Q9BY41 2/20 0.40
POLB P06746 1/20 0.38
BRD4 O60885 1/20 0.37
CREBBP Q92793 1/20 0.37
THRB P10828 1/20 0.37
RECQL P46063 1/20 0.37
ITK Q08881 2/20 0.36
CNR2 P34972 2/20 0.36
NR3C1 P04150 2/20 0.35
PGR P06401 1/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
OPRM1 P35372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6976898 0.87 F2 (0.49) HDAC1HDAC8THRBRECQLCNR2
SCHEMBL6980944 0.86 F2 (0.44) HDAC1HDAC8POLBRECQLNR3C1
SCHEMBL6980052 0.80 F2 (0.50) HDAC1HDAC8POLBBRD4CREBBP
SCHEMBL7672461 0.79 F2 (0.53) HDAC1HDAC8THRBRECQLCNR2
SCHEMBL6972029 0.79 F2 (0.40) HDAC1HDAC8POLBTHRBRECQL
SCHEMBL7664507 0.79 HDAC1 (0.46) HDAC1HDAC8THRBRECQLCNR2
SCHEMBL7664418 0.78 F2 (0.53) HDAC1HDAC8THRBRECQLF2
SCHEMBL6977229 0.78 TSHR (0.42) POLBRECQLCNR2MEN1MAPT
SCHEMBL6983580 0.78 F2 (0.52) HDAC1HDAC8CNR2F2
SCHEMBL7667594 0.77 F2 (0.55) HDAC1HDAC8CNR2MAPTF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1220844-B1 ARYL SULFONAMIDE-SUBSTITUTED BENZIMIDAZOL DERIVATIVES THEREOF AS TRYPTASE INHIBITORS BOEHRINGER INGELHEIM PHARMA (DE) 2003-04-09 EP disclosed
EP-1220844-A1 ARYL SULFONAMIDE-SUBSTITUTED BENZIMIDAZOL DERIVATIVES THEREOF AS TRYPTASE INHIBITORS Boehringer Ingelheim Pharma KG (DE) 2002-07-10 EP disclosed
US-6365584-B1 FOR PROPHYLAXIS AND THERAPY OF INFLAMMATORY AND/OR ALLERGIC DISEASES, LUNG FIBROSIS, FIBROSING ALVEOLITIS AND SCARRING, COLLAGENOSES SUCH AS LUPUS ERYTHEMATODES AND SCLERODERMIA AS WELL AS ARTERIOSCLEROSIS, PSORIASIS AND NEOPLASM BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-04-02 US disclosed
WO-2001023360-A1 ARYL SULFONAMIDE-SUBSTITUTED BENZIMIDAZOL DERIVATIVES THEREOF AS TRYPTASE INHIBITORS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-04-05 WO disclosed